Impact of COVID-19 on cervical cancer screening: Challenges and opportunities to improving resilience and reduce disparities

Wentzensen, Nicolas; Clarke, Megan A.; Perkins, Rebecca B.

doi:10.1016/j.ypmed.2021.106596

Cited by 82 publications

(86 citation statements)

References 86 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This finding was consistent with that of a study in a safety net hospital in San Francisco, where there was a reduction in the cumulative number of mammograms compared with the pre-COVID-19 era [22]. Another study reported that cervical cancer screenings declined after the national emergency declaration and remained 35% below the historical average [31]. The screening participation rate for colorectal and gastric cancer decreased more in women aged 70 years and older than in men of the same age group (percentage change: -12.4% vs. -16.6% for colorectal cancer; -12.0% in men vs. -14.7% in women for gastric cancer) (Supplementary Tables 1-2).…”

Section: E P U B a H E A D O F P R I N Tsupporting

confidence: 88%

The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea

et al. 2022

View full text Add to dashboard Cite

Objectives:The COVID-19 pandemic has affected the utilization of healthcare services, such as participation in cancer screening programs. We compared cancer screening participation rates for colorectal, gastric, breast, and cervical cancers among participants in the National Cancer Screening Program (NCSP) in 2019 and 2020 to address the potential distraction effect of COVID-19 on cancer screening.Methods: Data from the NCSP for four cancer types (stomach, colorectal, breast and cervical) in 2019 and 2020 were used to calculate cancer screening participation rates by calendar month, gender, age group, and geographical region. Monthly participation rates were analyzed per 1,000 eligible individuals. Results:The screening participation rate decreased in 2020 compared to 2019 for all four cancers: colorectal (40.5% vs. 35.3%), gastric (61.9% vs. 54.6%), breast (63.8% vs. 55.8%), and cervical cancers (57.8% vs. 52.2%). Following two major COVID-19 waves in March and December 2020, the participation rates in the four types of cancer screening dropped compared with those in 2019. The highest decline was observed in the elderly population aged 80 years and older (percentage change: -21% for colorectal cancer; -20% for gastric cancer; -26% for breast cancer; -20% for cervical cancer). Conclusions:After the two major COVID-19 waves, the screening participation rate for the four types of cancer declined compared with 2019. Further studies are needed to identify the indirect effects of the COVID-19 pandemic on cancer patients, such as delayed diagnosis of cancer or excess cancer deaths.

show abstract

Section: E P U B a H E A D O F P R I N Tsupporting

confidence: 88%

The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea

et al. 2022

View full text Add to dashboard Cite

show abstract

“…There were few opportunities for primary and secondary prevention of cervical cancer and the availability of telehealth visits did not address the need for in-person examination during the pandemic. 2…”

Section: The Unmeasured Impact Of Medical Care Missed or Delayed By C...mentioning

confidence: 99%

The ASCCP President's Message

Flowers

2022

J Low Genit Tract Dis

View full text Add to dashboard Cite

I t is with great excitement and enthusiasm that I assume the presidency of the ASCCP. I must start with a tribute to my predecessor, Dr Chelmow, and our CEO, Kerry Curtis, who navigated this organization and its educational mission through the many challenges of the COVID-19 pandemic. Their innovative expansion of virtual educational opportunities and guidance on using the 2019 ASCCP Risk-Based Management Consensus Guidelines 1 to optimize patient care despite systems-based limitations has been remarkable. The mission of ASCCP has shaped this organization into a leader in the management of anogenital and human papillomavirus (HPV)-related disease. It is my honor to guide our community to the next frontier: reversing the harms of the pandemic.

show abstract

“…The COVID-19 pandemic has also caused disruptions to nonemergency procedures, including cervical cancer screening. 38 Moreover, access to providers who offer HPV testing is a significant obstacle for women in low-resource settings.…”

Section: Early Detection For the Preventive Care Of Hpv-related Cancermentioning

confidence: 99%

Gaps and Opportunities to Improve Prevention of Human Papillomavirus-Related Cancers

Aninye

Berry-Lawhorn

Blumenthal

et al. 2021

Journal of Women's Health

View full text Add to dashboard Cite

Human papillomavirus (HPV) infections cause more than 35,900 cancers annually in the United States. Although cervical cancer is the most prevalent HPV-related malignancy in women, the virus is also responsible for a significant percentage of anal, vaginal, and vulvar cancers. A comprehensive approach to mitigating cervical cancer includes HPV vaccination (primary prevention), screening and treatment of precancerous lesions (secondary prevention), and diagnosis and treatment of invasive cancer (tertiary prevention). Although a successful strategy, there are opportunities to innovate and increase access that can also be adapted to address the unique clinical care gaps that exist with the other anogenital cancers. The Society for Women's Health Research held a series of interdisciplinary meetings and events, during which expert researchers, clinicians, patient advocates, and health care policy leaders evaluated the current landscape of HPV-related cancers and their effects on women's health. This report summarizes the discussions of this working group and areas it identified in which to address gaps in primary and secondary prevention approaches to improve access and health outcomes for women with HPV-related anogenital cancers.

show abstract

Impact of COVID-19 on cervical cancer screening: Challenges and opportunities to improving resilience and reduce disparities

Cited by 82 publications

References 86 publications

The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea

The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea

The ASCCP President's Message

Gaps and Opportunities to Improve Prevention of Human Papillomavirus-Related Cancers

Contact Info

Product

Resources

About